Literature DB >> 28689506

Description and validation of a new automated surveillance system for Clostridium difficile in Denmark.

M Chaine1, S Gubbels1, M Voldstedlund1, B Kristensen1, J Nielsen1, L P Andersen2, S Ellermann-Eriksen3, J Engberg4, A Holm5, B Olesen6, H C Schønheyder7, C Østergaard8, S Ethelberg1, K Mølbak9.   

Abstract

The surveillance of Clostridium difficile (CD) in Denmark consists of laboratory based data from Departments of Clinical Microbiology (DCMs) sent to the National Registry of Enteric Pathogens (NREP). We validated a new surveillance system for CD based on the Danish Microbiology Database (MiBa). MiBa automatically collects microbiological test results from all Danish DCMs. We built an algorithm to identify positive test results for CD recorded in MiBa. A CD case was defined as a person with a positive culture for CD or PCR detection of toxin A and/or B and/or binary toxin. We compared CD cases identified through the MiBa-based surveillance with those reported to NREP and locally in five DCMs representing different Danish regions. During 2010-2014, NREP reported 13 896 CD cases, and the MiBa-based surveillance 21 252 CD cases. There was a 99·9% concordance between the local datasets and the MiBa-based surveillance. Surveillance based on MiBa was superior to the current surveillance system, and the findings show that the number of CD cases in Denmark hitherto has been under-reported. There were only minor differences between local data and the MiBa-based surveillance, showing the completeness and validity of CD data in MiBa. This nationwide electronic system can greatly strengthen surveillance and research in various applications.

Entities:  

Keywords:  zzm321990 Clostridium difficilezzm321990 ; gastrointestinal infections; hospital-acquired (nosocomial) infections; surveillance system

Mesh:

Year:  2017        PMID: 28689506      PMCID: PMC9148787          DOI: 10.1017/S0950268817001315

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  20 in total

1.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors:  Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  Automated surveillance of Clostridium difficile infections using BioSense.

Authors:  Stephen R Benoit; L Clifford McDonald; Roseanne English; Jerome I Tokars
Journal:  Infect Control Hosp Epidemiol       Date:  2010-12-03       Impact factor: 3.254

3.  Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.

Authors:  Thomas Akerlund; Bo Svenungsson; Asa Lagergren; Lars G Burman
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

4.  Cesarean delivery and risk of intestinal bacterial infection.

Authors:  Peter Bager; Jacob Simonsen; Steen Ethelberg; Morten Frisch
Journal:  J Infect Dis       Date:  2010-03-15       Impact factor: 5.226

5.  Heterogeneity of Clostridium difficile isolates from infants.

Authors:  A Collignon; L Ticchi; C Depitre; J Gaudelus; M Delmée; G Corthier
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

6.  Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.

Authors:  Annie-Claude Labbé; Louise Poirier; Duncan Maccannell; Thomas Louie; Michel Savoie; Claire Béliveau; Michel Laverdière; Jacques Pépin
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

7.  Clostridium difficile outbreaks: prevention and treatment strategies.

Authors:  Fernando J Martinez; Daniel A Leffler; Ciaran P Kelly
Journal:  Risk Manag Healthc Policy       Date:  2012-07-03

8.  Binary toxin and death after Clostridium difficile infection.

Authors:  Sabrina Bacci; Kåre Mølbak; Marianne K Kjeldsen; Katharina E P Olsen
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

Review 9.  Clostridium difficile in Children: To Treat or Not to Treat?

Authors:  Jung Ok Shim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2014-06-30

10.  Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.

Authors:  A Sarah Walker; David W Eyre; David H Wyllie; Kate E Dingle; David Griffiths; Brian Shine; Sarah Oakley; Lily O'Connor; John Finney; Alison Vaughan; Derrick W Crook; Mark H Wilcox; Tim E A Peto
Journal:  Clin Infect Dis       Date:  2013-03-05       Impact factor: 20.999

View more
  3 in total

1.  Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Emma E Ilett; Marie Helleberg; Joanne Reekie; Daniel D Murray; Signe M Wulff; Mark P Khurana; Amanda Mocroft; Gedske Daugaard; Michael Perch; Allan Rasmussen; Søren S Sørensen; Finn Gustafsson; Niels Frimodt-Møller; Henrik Sengeløv; Jens Lundgren
Journal:  Open Forum Infect Dis       Date:  2019-02-19       Impact factor: 3.835

2.  The Economic Burden of Clostridioides difficile in Denmark: A Retrospective Cohort Study.

Authors:  Uffe Christian Braae; Frederik Trier Møller; Rikke Ibsen; Steen Ethelberg; Jakob Kjellberg; Kåre Mølbak
Journal:  Front Public Health       Date:  2020-11-26

3.  Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018.

Authors:  Katrin Claire Leitmeyer; Laura Espinosa; Eeva Kaarina Broberg; Marc Jean Struelens
Journal:  Euro Surveill       Date:  2020-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.